Brief: Neoleukin Therapeutics Files For Offering Of 15.3 Million Shares Of Common Stock By Selling Stockholder - SEC Filing
09/05/2022 22:27
May 9 (Reuters) - Neoleukin Therapeutics Inc NLTX.O :
* NEOLEUKIN THERAPEUTICS FILES FOR OFFERING OF 15.3 MILLION
SHARES
OF COMMON STOCK BY SELLING STOCKHOLDER - SEC FILING
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Neurogene
See all newsBrief: Neurogene Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Neurogene Inc reports results for the quarter ended June 30 - Earnings Summary
Neurogene Q2 adjusted loss per share misses estimates on employee costs
Neurogene Inc expected to post a loss of $1.42 a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Kroger, Meta, Sable